News

Embryo Experiments Reveal Earliest Human Development, But Stir Ethical Debate

Ali Brivanlou slides open a glass door at the Rockefeller University in New York to show off his latest experiments probing the mysteries of the human embryo. “As you can see, all my lab is glass — just to make sure there is nothing that happens in some dark rooms that gives people some weird … Continued

Read More

PRESS RELEASE: The Pershing Square Sohn Cancer Research Alliance Now Accepting Applications for the 2017 Prize for Young Investigators in Cancer Research

The Pershing Square Sohn Cancer Research Alliance (PSSCRA) today announced the opening of applications for its Prize for Young Investigators in Cancer Research. The prize of $200,000 per year for up to three years is awarded annually to at least five New York City-based scientists, enabling them to continue to pursue explorative and high-risk/high-reward research at a stage when traditional funding is lacking.

Read More

PRESS RELEASE: The Pershing Square Sohn Cancer Research Alliance announces 2016 winners

The Pershing Square Sohn Cancer Research Alliance (“the Alliance”) today announced seven winners of the third annual Pershing Square Sohn Prize for Young Investigators in Cancer Research (“the Pershing Square Sohn Prize”). Each will receive $200,000 in funding per year for up to three years to enable them to continue to pursue explorative and high-risk/high-reward research.

Read More

How Not to End Cancer in Our Lifetimes

President Obama calls the quest to cure cancer the “moon shot” of his presidency. But if the federal government has its way, this rocket may never leave the launchpad.

Read More

Jennifer Doudna: The Promise and Peril of Gene Editing

Geneticist Jennifer Doudna on the controversy about Crispr-Cas9, a technique that could potentially cure genetic diseases.

Read More

Financing High-Risk Medical Research

A Proposal from FasterCures by Melissa Stevens (Milken Institute Review) - In the past few years, the media has showered us with headlines about recordsetting biotech financing – outsized venture-capital rounds, unprecedented public market appetite for IPOs, and robust sector returns. But a closer look suggests there is more froth than substance at this frontier of medicine and science.

Read More

Could 2015 Be a Turning Point in NIH Funding?

For the National Institutes of Health and its supporters, 2015 could turn out to be a pretty good year. As Congress continues negotiations on a mammoth omnibus spending package, advocates are hopeful that their favored institution is becoming a congressional priority again—and that an extended period of uncertainty may be coming to a close.

Read More

Cell scientist to watch – Christine Mayr

Abstract: Before completing a PhD in immunology at the Humbolt University of Berlin, Christine Mayr received a medical degree from the Freie Universität Berlin. She received postdoctoral training with Michael Hallek at the Ludwig Maximillian University in Munich.

Read More

If Cancer Becomes Biden’s Cause, a Bold but Polarizing Doctor Is On Call

WASHINGTON — One day last winter, desperate as his son fought for his life against a killer brain cancer, Vice President Joseph R. Biden Jr. and his family reached out to one of America’s most famous, and controversial, doctors for help.

Read More

Tumor Exosome Protein Signatures Predict Future Organ Sites of Cancer Spread

Findings By Weill Cornell Medicine Explain Paget’s “Seed and Soil” Theory of Metastasis

Read More